Urology Annals
About UA | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionLogin 
Urology Annals
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 161   Home Print this page  Email this page Small font size Default font size Increase font size

    Article Cited by others

ORIGINAL ARTICLE

Prospective randomized trial of 100u vs 200u botox in the treatment of idiopathic overactive bladder

AlTaweel Waleed, Mokhtar Alaa, Rabah Danny M

Year : 2011| Volume: 3| Issue : 2 | Page no: 66-70

   This article has been cited by
 
1 Randomized clinical trials assessing third-line therapies to treat non-neurogenic overactive bladder syndrome: a review about methodology
Pierre-Luc Dequirez, Xavier Biardeau
International Urogynecology Journal. 2021; 32(10): 2603
[Pubmed]  [Google Scholar] [DOI]
2 Antibiotic regimen and route of administration do not alter rates of urinary tract infection after intravesical botulinum toxin injection for overactive bladder
Sarah E. Eckhardt, Yoko Takashima, Stephanie J. Handler, Christopher Tenggardjaja, Tajnoos Yazdany
International Urogynecology Journal. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 Routine Office Assessment After OnabotulinumtoxinA Injection for Overactive Bladder Is Unnecessary to Detect Clinically Significant Voiding Dysfunction
Emily R. Aldrich, Rachel N. Pauls
Female Pelvic Medicine & Reconstructive Surgery. 2021; 27(4): 225
[Pubmed]  [Google Scholar] [DOI]
4 Guideline of guidelines: urinary incontinence in women
Rachael D. Sussman, Raveen Syan, Benjamin M. Brucker
BJU International. 2020; 125(5): 638
[Pubmed]  [Google Scholar] [DOI]
5 Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
Qin-Qin Gong, Yu-Qiong Xu, Jun Xu, Xiao-Yan Ding, Chong Guo
Frontiers in Pharmacology. 2020; 10
[Pubmed]  [Google Scholar] [DOI]
6 OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera,Christopher R Chapple
Clinical Investigation. 2014; 4(3): 281
[Pubmed]  [Google Scholar] [DOI]
7 An Updated Systematic Review and Statistical Comparison of Standardised Mean Outcomes for the Use of Botulinum Toxin in the Management of Lower Urinary Tract Disorders
Altaf Mangera,Apostolos Apostolidis,Karl Eric Andersson,Prokar Dasgupta,Antonella Giannantoni,Claus Roehrborn,Giacomo Novara,Christopher Chapple
European Urology. 2013;
[Pubmed]  [Google Scholar] [DOI]
8 Sacral neuromodulation and intravesical botulinum toxin for refractory overactive bladder
Kantartzis, K. and Shepherd, J.
Current Opinion in Obstetrics and Gynecology. 2012; 24(5): 331-336
[Pubmed]  [Google Scholar]
9 Virtual trainer for intra-detrusor injection of botulinum toxin to treat urinary incontinence
Shen, Y., Vasandani, P., Iyer, J., Gunasekaran, A., Zhang, Y., Burke, D., Dykstra, D., Sweet, R.
Studies in Health Technology and Informatics. 2012; 173: 457-462
[Pubmed]  [Google Scholar]

 

Read this article